Cardiovascular safety of Osimertinib in non-small cell lung cancer patients

被引：0
|
作者：
Chavan, Ashish [1 ]
Shirsat, Aditi [1 ]
Chopade, Sunil [1 ]
Menon, Nandini [1 ]
Patil, Vijay [1 ]
Noronha, Vanita [1 ]
Gota, Vikram [1 ]
Prabhash, Kumar [1 ]
Nookala, Manjunath [1 ]
机构：
[1] Tata Mem Hosp, Actrec, Parel, India
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0858
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [21] Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients
    Janpipatkul, Keatdamrong
    Trachu, Narumol
    Watcharenwong, Piyakarn
    Panvongsa, Wittaya
    Worakitchanon, Wittawin
    Metheetrairut, Chanatip
    Oranratnachai, Songporn
    Reungwetwattana, Thanyanan
    Chairoungdua, Arthit
    CANCER BIOMARKERS, 2021, 31 (03) : 281 - 294
  • [22] Osimertinib for treating Patients with EGFR Mutation-Positive non-small cell Lung Cancer
    Meinrenken, Susanne
    PNEUMOLOGIE, 2018, 72 (04): : 246 - 246
  • [23] Integrating Osimertinib in Clinical Practice for Non-Small Cell Lung Cancer Treatment
    Senthil Rajappa
    M. Vamshi Krishna
    Prasad Narayanan
    Advances in Therapy, 2019, 36 : 1279 - 1290
  • [24] Integrating Osimertinib in Clinical Practice for Non-Small Cell Lung Cancer Treatment
    Rajappa, Senthil
    Krishna, M. Vamshi
    Narayanan, Prasad
    ADVANCES IN THERAPY, 2019, 36 (06) : 1279 - 1290
  • [25] An overview of osimertinib as a treatment of non-small cell lung cancer (NSCLC): an update
    Cerbone, Luigi
    Benitez, Jose Carlos
    Planchard, David
    Genova, Carlo
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (07) : 809 - 819
  • [26] Pharmacokinetic drug evaluation of osimertinib for the treatment of non-small cell lung cancer
    Rossi, Antonio
    Muscarella, Lucia Anna
    Di Micco, Concetta
    Carbonelli, Cristiano
    D'alessandro, Vito
    Notarangelo, Stefano
    Palomba, Giuseppe
    Sanpaolo, Gerardo
    Taurchini, Marco
    Graziano, Paolo
    Maiello, Evaristo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (12) : 1281 - 1288
  • [27] Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies
    Tang, Zheng-Hai
    Lu, Jin-Jian
    CANCER LETTERS, 2018, 420 : 242 - 246
  • [28] Surgery for non-small cell lung cancer in patients with a history of cardiovascular surgery
    Hideyuki Maeda
    Masato Kanzaki
    Kei Sakamoto
    Tamami Isaka
    Kenji Yamazaki
    Takamasa Onuki
    Surgery Today, 2017, 47 : 284 - 292
  • [29] Surgery for non-small cell lung cancer in patients with a history of cardiovascular surgery
    Maeda, Hideyuki
    Kanzaki, Masato
    Sakamoto, Kei
    Isaka, Tamami
    Yamazaki, Kenji
    Onuki, Takamasa
    SURGERY TODAY, 2017, 47 (03) : 284 - 292
  • [30] Cardiovascular events in eGFR-mutation non-small-cell lung cancer patients on osimertinib
    Mensah, Samuel Akaakole
    Ahmad, Syed
    Alruwaili, Waleed
    Raval, Rutu
    Gonuguntla, Karthik
    Patel, Brijesh
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
12345